PREVIOUSLY RECORDED WEBINAR

DESCRIPTION

In July 2021 the Centers for Disease Control and Prevention published an update to the sexually transmitted infections (STIs) Treatment Guidelines including diagnostic considerations for a number of sexually transmitted infections. Come hear what is new and how it may impact your current or future testing. Speakers will address topics such as testing for Mycoplasma genitalium and detection of antimicrobial resistance markers, numerous testing needs for Neisseria gonorrhoeae including test of cure as well as a two-step algorithm for herpes simplex virus testing.

OBJECTIVES

At the conclusion of the program, the participant will be able to:

Describe current recommendations for STI testing
Identify new approaches to STI testing to meet the testing recommendations
Summarize how STI testing recommendations help to improve clinical management and control of STIs

FACULTY

Laura Hinkle Bachmann, MD, MPH, FIDSA, chief medical office, division of STD prevention, CDC
Lindley Barbee, MD, MPH, associate professor, infectious diseases, University of Washington, medical consultant, division of STD prevention, CDC
Christine Johnston, MD, MPH, associate professor, division of allergy & infectious diseases, University of Washington
Evelyn Nash, PhD, gonorrhea clinical activities unit lead, division of STD prevention, CDC
Brian H. Raphael, PhD, lead, gonorrhea, ghlamydia, and M. genitalium team, division of STD prevention, CDC

AUDIENCE

This program is intended for anyone who works in or supervises a public health or clinical laboratory, including clinical and public health laboratory staff, microbiology students, epidemiologists and research scientists.

ERRATUM:

Please note an oversight on behalf of the presenters: The cobas CT/NG assay on the 6800/8800 systems has also been FDA approved for pharyngeal specimens. To date there is no data to suggest it cross-reacts with commensal Neisseria species.

CONTINUING EDUCATION

The Association of Public Health Laboratories (APHL) is approved as a provider of continuing education programs in the clinical laboratory sciences by the ASCLS P.A.C.E.® Program, Florida and CPH-recertification. P.A.C.E.® is accepted by all licensure states except Florida. This webinar will provide 1.0 contact hour for participants who successfully complete this training until December 8, 2022. After this date, you can no longer obtain P.A.C.E.® for this webinar.

CREATE AN ACCOUNT WITH APHL!

If you do not have an account with us, you will need to create an account before attempting to register. Through your account portal you will be able to track your events, invoices, transactions and much more!

If you already have an account, make sure you login before registering!

Contact admin.sp@aphl.org with any login or account questions. Review this guide for help with the registration process.

REGISTRATION CONSENT

By registering for this event, you are consenting to have your information shared with APHL event stakeholders, such as the Centers for Disease Control and Prevention and Public Health Labs. We will not, in any circumstances, share your information with other individuals or organizations without your permission, including corporations or individuals, except when applicable by law. We do not sell, communicate or divulge your information to any mailing lists.

Your Email:
Your Question:	Send Question

2021 STI Treatment Guidelines—What does the laboratory need to know? (588-632-21) .wc-legacyPageTitle, .GeneralHeader, .HeaderStyle1, #wc-eventDetailsPageTitle, #wc-eventRegistrationPageTitle { display: none!important; }

Sponsors

Related Links

Attendees

Questions

2021 STI Treatment Guidelines—What does the laboratory need to know? (588-632-21)